AAV9 Capsid Variants with Improved CNS Transduction Identified by Directed Evolution

被引：0

作者：

Rohovie, Marcus ^{[1
]}

Kruse, Nikki ^{[1
]}

Schmitt, Christopher ^{[1
]}

Wong, Victoria ^{[1
]}

Sero, Antoinette ^{[1
]}

Rivera-Velazquez, Mirella ^{[1
]}

Lee, Grace ^{[1
]}

Desautel, Sarah ^{[1
]}

Del Greco, Elizabeth ^{[1
]}

Sedighi, Faezeh ^{[1
]}

Nivina, Aleksandra ^{[1
]}

Jenne, Stephan ^{[1
]}

Gebretsadik, Kahsay ^{[1
]}

Kumar, Ambuj ^{[1
]}

Chng, Chinping ^{[1
]}

Akeefe, Hassibullah ^{[1
]}

Silverman, Adam ^{[1
]}

机构：

[1] Codexis Inc, San Carlos, CA USA

来源：

MOLECULAR THERAPY | 2023年 / 31卷 / 04期

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

1400

引用

页码：661 / 661

页数：1

共 50 条

[31] Intravenous administration of engineered AAV gene therapy capsid demonstrates improved CNS transduction in adult mice
Murlidharan, G.
Adachi, K.
Wang, H.
Nguyen, T.
Johnson, B.
Liu, L.
Zhou, J.
Felix-Ortiz, A.
Christensen, E.
Aubin, J.
Goulet, M.
Thompson, J.
Carter, T.
Hou, J.
Sah, D.
HUMAN GENE THERAPY, 2018, 29 (12) : A79 - A79
[32] Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
Chatterjee, Diptaman
Marmion, David J.
McBride, Jodi L.
Manfredsson, Fredric P.
Butler, David
Messer, Anne
Kordower, Jeffrey H.
GENE THERAPY, 2022, 29 (06) : 390 - 397
[33] Peptide Ligands Incorporated into the Threefold Spike Capsid Domain to Re-Direct Gene Transduction of AAV8 and AAV9 In Vivo
Michelfelder, Stefan
Varadi, Karl
Raupp, Christina
Hunger, Agnes
Koerbelin, Jakob
Pahrmann, Christiane
Schrepfer, Sonja
Mueller, Oliver J.
Kleinschmidt, Juergen A.
Trepel, Martin
PLOS ONE, 2011, 6 (08):
[34] Enhanced CNS transduction from AAV.PHP.eB infusion into the cisterna magna of older adult rats compared to AAV9
Diptaman Chatterjee
David J. Marmion
Jodi L. McBride
Fredric P. Manfredsson
David Butler
Anne Messer
Jeffrey H. Kordower
Gene Therapy, 2022, 29 : 390 - 397
[35] Improved AAV1 and AAV9 Vectors for Gene Delivery
Balakrishnan, Balaji
Krishnagopal, Akshaya
Sen, Dwaipayan
Srivastava, Alok
Jayandharan, Giridhara R.
MOLECULAR THERAPY, 2013, 21 : S130 - S131
[36] The human brain endothelial barrier: transcytosis of AAV9, transduction by AAV2
Weber-Adrian, Danielle
Heinen, Stefan
Silburt, Joseph
Noroozian, Zeinab
Aubert, Isabelle
JOURNAL OF NEUROCHEMISTRY, 2017, 140 (02) : 192 - 194
[37] Engineered AAV Capsid Variants for Improved Ocular Delivery
Nachtrab, Greg
Wilson, Alistair
Geddes, Claire
Narayan, Nandini
Batra, Ranjan
Gibbs, Dan
MOLECULAR THERAPY, 2021, 29 (04) : 144 - 144
[38] Directed Evolution of AAV Capsid for Targeted Cancer Therapy
Marsic, Damien
Lu, Yuan
Cao, Chunxia
Phelan, Dane
Govindasamy, Lakshmanan
Kaye, Frederic J.
Agbandje-McKenna, Mavis
Ghivizzani, Steve
Zolotukhin, Sergei
MOLECULAR THERAPY, 2013, 21 : S130 - S130
[39] CNS-Directed AAV9 Gene Therapy for the Treatment of Canine Globoid Cell Leukodystrophy (Krabbe Disease)
Bradbury, Allison M.
Bagel, Jessica H.
Hendricks, Ian J.
Duc Nguyen
Bongarzone, Ernesto R.
Gray, Steven J.
Vite, Charles H.
MOLECULAR THERAPY, 2019, 27 (04) : 189 - 189
[40] Engineered AAV capsids with significantly improved muscle and CNS tropism plus reduced liver and DRG expression compared to AAV9
Olivieri, K.
Tan, J.
Huang, L.
Lee, J.
Malyszka, S.
Siripurapu, S.
Fieldsend, A.
Pryce, C.
Edwards, T. M.
Mastis, B.
Calcedo, R.
Richman, L.
Cao, S.
Albright, C.
Reece-Hoyes, J. S.
HUMAN GENE THERAPY, 2024, 35 (3-4) : A75 - A75

← 1 2 3 4 5 →